Clinical Trial Update: OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer [Phase 3]

View source ↗

Summary

Phase III trial OVATURE comparing weekly carboplatin with and without phenoxodiol in platinum-resistant recurrent epithelial ovarian cancer has completed enroll…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Phenoxodiol

Snippet

Sponsor: MEI Pharma, Inc. | Conditions: Fallopian Tube Cancer, Peritoneal Neoplasms | Phase 3 | Status: COMPLETED